Genomic imbalances in peripheral blood confirm the diagnosis of myelodysplastic syndrome in a patient presenting with non-immune hemolytic anemia
This report highlights the importance of suspecting MDS in patients with cytopenias and microangiopathic hemolytic anemia. CMA of peripheral blood may assist in the preliminary diagnosis of MDS, representing a comparatively less invasive diagnostic procedure and may aid bone marrow evaluation when aspirate sample is insufficient for conventional cytogenetic analysis.
Source: Leukemia Research Reports - Category: Hematology Source Type: research
More News: Anemia | Hematology | Leukemia | Microangiopathic Hemolytic Anemia | Myelodysplastic Syndrome | Stem Cell Therapy | Stem Cells